For more information or confidential assistance
800-306-3180
se habla español

Bellwether Selection for Nexium, Prilosec Lawsuits Stalls

Thousands of plaintiffs who have filed lawsuits regarding Nexium, Prilosec, and similar medications have been looking forward to having their claims heard in court. However, the process of selecting cases for bellwether trials has hit a snag. Originally, the court instructed the involved parties to submit their final, agreed-upon plan... Read more »

Taxotere Lawsuits Centralized under Multidistrict Litigation

Earlier in October, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a consolidation order for Taxotere lawsuits filed in federal courts around the country. The claims will now proceed in a multidistrict litigation (MDL) against defendant Sanofi-Aventis. The ruling affects at least 33 cases that had been pending in 16 different U.S.... Read more »

New Study Highlights Nexium Dangers

Recent large scale epidemiological and retrospective studies have demonstrated links between the use of proton pump inhibitors (PPIs) and an increased risk of renal failure, myocardial infarction and dementia. On top of this, medical experts say that up to 70 percent of patients that take PPIs for treatment of heartburn... Read more »

GSK Seeks to Consolidate Zofran Lawsuits Alleging Birth Defects

GlaxoSmithKline has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Zofran lawsuits for coordinated pretrial proceedings. As the number of product liability lawsuits filed on behalf of children born with heart defects, cleft palate and other congenital defects allegedly caused by exposure... Read more »